Used as an intermediate in pharmaceutical synthesis, particularly in the development of bioactive molecules targeting central nervous system disorders such as antidepressants or anxiolytics. Its structure, featuring a sulfonyl and piperazine moiety attached to a 3-(trifluoromethyl)phenyl group, supports modulation of receptor binding in the brain, making it valuable in creating novel psychotropic or neuroprotective agents. The trifluoromethyl group provides electron-withdrawing properties and stability. Also employed in agrochemical research for designing new herbicides and pesticides. Commonly utilized in medicinal chemistry for structure-activity relationship (SAR) studies involving sulfonamide-containing compounds, enabling the creation of derivatives with improved efficacy and safety.